Salcatonin(Salmon Calcitonin)

Generic Name
Salcatonin(Salmon Calcitonin)
Brand Names
Calcimar, Fortical, Miacalcin
Drug Type
Biotech
Chemical Formula
-
CAS Number
47931-85-1
Unique Ingredient Identifier
7SFC6U2VI5
Background

Synthetic peptide, 32 residues long formulated as a nasal spray.

Indication

⑴绝经后骨质疏松症,老年骨质疏松症。

⑵乳癌、肺或肾癌、骨髓瘤和其他恶性肿瘤骨转移所致的大量骨溶解和高钙血症。

⑶各种骨代谢疾病所致的骨痛。

⑷甲状旁腺功能亢进、缺乏活动或维生素D中毒(包括急性或慢性中毒)所致的变应性骨炎。

⑸Paget病。

⑹高钙血症和高钙血症危象。

Associated Conditions
Hypercalcemia, Osteoporosis, Paget’s Disease, Symptomatic Paget's disease
Associated Therapies
-

Calcitonin in the Treatment of Fibromyalgia

First Posted Date
2008-09-18
Last Posted Date
2015-12-04
Lead Sponsor
Unidad de Investigacion en Enfermedades Cronico-Degenerativas
Registration Number
NCT00754884
Locations
🇲🇽

Hospital General Regional No. 45, IMSS, Guadalajara, Jalisco, Mexico

A Study for Patients With Osteoporosis

Phase 3
Completed
Conditions
Interventions
First Posted Date
2006-12-22
Last Posted Date
2009-10-28
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
364
Registration Number
NCT00414973
Locations
🇨🇳

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Wenzhou, China

Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women

Phase 3
Completed
Conditions
First Posted Date
2006-09-06
Last Posted Date
2011-12-23
Lead Sponsor
Rene Rizzoli
Target Recruit Count
90
Registration Number
NCT00372099

Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women

Phase 4
Completed
Conditions
First Posted Date
2005-10-17
Last Posted Date
2006-11-30
Lead Sponsor
Novartis
Target Recruit Count
300
Registration Number
NCT00239889
Locations
🇨🇭

Novartis, Basel, Switzerland

© Copyright 2024. All Rights Reserved by MedPath